Cadence Biomedical is a commercial-stage medical device company founded in 2007 and headquartered in Seattle, Washington. The company is focused on advancing neurorehabilitation in collaboration with healthcare professionals, patients, and caregivers. Their primary commercial product, Kickstart®, is a neurorehabilitation device specifically designed to expedite the recovery to walking in individuals affected by conditions such as stroke, multiple sclerosis, spinal cord injury, and other progressive neurological conditions. Kickstart is available for use in physical therapy during the initial recovery process and as a prescribed device for post-discharge use in community and home settings. In the latest funding round, Cadence Biomedical secured a $1.20M Series B investment on 25 June 2015 from investors including Frontier Angel Fund, SandHill Angels, HealthTech Capital, and BioPacific Ventures. For more information, visit www.cadencebiomedical.com.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | $1.20M | 4 |
|
25 Jun 2015 |
| Series A | Unknown | 1 |
|
01 Jan 2013 |
| Series A | $1.10M | 5 |
|
26 Apr 2012 |
| Venture Round | $750.00K | - | 20 Jan 2012 | |
| Series A | Unknown | - | 01 Jan 2011 |
No recent news or press coverage available for Cadence Biomedical.
We care about your data, and we'd love to use cookies make your experience better.